Skip to main content
. 2020 Jun 30;2020:2856460. doi: 10.1155/2020/2856460

Table 3.

SF36 domains (norm-based scales) and PSQI global score at baseline and final follow-up (12 months), based on per-protocol analysis (compliant patients only).

SF36 domains Baseline Follow-up Adj. difference (95% CI)§ p §
CPAP (n = 18) MAS (n = 36) CPAP (n = 18) MAS (n = 36)
Physical functioning 47.9 (9.0) 48.3 (7.7) 49.8 (8.3) 49.7 (9.1) −0.8 (−4.5–2.8) 0.64
Role-physical 49.4 (6.3) 48.4 (9.0) 50.4 (7.2) 50.2 (8.3) −0.3 (−4.1–3.6) 0.89
Bodily pain 48.4 (12.4) 46.7 (10.3) 47.7 (11.7) 46.9 (11.5) 0.1 (−5.8–6.0) 0.97
General health 45.9 (10.2) 46.9 (10.5) 49.1 (10.5) 49.2 (10.1) −0.4 (−4.9–4.2) 0.88
Vitality 43.2 (13.7) 39.8 (10.1) 51.0 (9.4) 50.2 (8.4) 0.0 (−5.3–5.2) 0.99
Social functioning 46.6 (12.7) 41.9 (13.0) 51.8 (8.7) 47.7 (9.3) −1.7 (−6.9–3.5) 0.51
Role-emotional 49.5 (7.3) 48.0 (8.8) 51.3 (6.4) 50.0 (7.4) 0.3 (−3.6–4.1) 0.89
Mental health 49.2 (8.8) 47.2 (12.4) 53.3 (8.1) 51.5 (8.2) −0.8 (−5.1–3.5) 0.71
Physical component score 47.7 (8.3) 47.9 (9.1) 48.2 (8.7) 48.5 (10.0) 0.0 (−3.6–3.7) 0.99
Mental component score 47.6 (9.6) 44.1 (12.5) 53.2 (4.9) 50.5 (8.0) −0.2 (−3.9–3.4) 0.91
PSQI global score 7.1 (3.4) 7.7 (3.3) 5.7 (2.3) 5.4 (2.5) −0.6 (−1.7–0.5) 0.25

CPAP: continuous positive airway pressure; MAS: mandibular advancement splint; PSQI: Pittsburgh Sleep Quality Index SF36: Medical Outcomes Study Short-Form 36-Element Health Survey; SF36 domains and PSQI global score: mean (standard deviation). Statistically significant change from baseline to follow-up within treatment group, paired t-test (p < 0.05). §Difference between MAS and CPAP treatment groups at follow-up, based on linear regression analysis adjusted for baseline variables (age, BMI, sex, smoking, baseline AHI, and the baseline SF36 domain/PSQI global score), reference group: CPAP.